Volume 26, Number 7—July 2020
Research
Burden and Cost of Hospitalization for Respiratory Syncytial Virus in Young Children, Singapore
Table 2
Age, mo | Outcome | Full cost (95% CI) | Subsidized cost (95% CI) |
---|---|---|---|
Hospitalizations | |||
<6 | All | $2,160,000 ($2,002,000–$2,352,000) | $1,321,000 ($1,168,000–$1,492,000) |
Bronchiolitis | $1,881,000 ($1,771,000–$1,995,000) | $1,127,000 ($1,006,000–$1,250,000) | |
Pneumonia | $152,000 ($82,000–$278,000) | $106,000 ($53,000–$198,000) | |
Pneumonia with complications | $119,000 ($55,000–$220,000) | $80,000 ($25,000–$167,000) | |
6–29 | All | $3,554,000 ($3,175,000–$4,118,000) | $2,236,000 ($1,932,000–$2,651,000) |
Bronchiolitis | $2,436,000 ($2,319,000–$2,563,000) | $1,459,000 ($1,328,000–$1,600,000) | |
Pneumonia | $573,000 ($321,000–$1,041,000) | $401,000 ($217,000–$729,000) | |
Pneumonia with complications |
$523,000 ($322,000–$857,000) |
$358,000 ($191,000–$610,000) |
|
Primary care consultations | |||
<6 | Primary care attendances | $177,000 ($153,000–$203,000) | $118,000 ($102,000–$136,000) |
6–29 |
Primary care attendances |
$280,000 ($246,000–$317,000) |
$187,000 ($163,000–$213,000) |
Hospitalizations and primary care consultations | |||
<6 | All | $2,337,000 ($2,175,000–$2,530,000) | $1,440,000 ($1,285,000–$1,611,000) |
6–29 | All | $3,833,000 ($3,454,000–$4,399,000) | $2,423,000 ($2,115,000–$2,838,000) |
<30 | All | $6,228,000 ($5,734,000–$6,950,000) | $3,899,000 ($3,506,000–$4,432,000) |
*Estimates are expressed as the medians from 10,000 Monte Carlo simulations. Note that the sum of medians from individual diagnoses does not equal the median for all diagnoses combined. All costs are in Singapore dollars. RSV, respiratory syncytial virus.
Page created: May 06, 2020
Page updated: June 18, 2020
Page reviewed: June 18, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.